Companion Diagnostics Market Research Reports & Industry Analysis
The companion diagnostics market is one of the fastest growing segments of the IVD and clinical lab services markets. In the United States, over half of all FDA approvals for companion diagnostics have occurred since 2010. The closely associated pharmacodiagnostics IVD market is expected to grow annually by over 20%. The wild success of reference laboratories in the companion diagnostics market even prompted the unprecedented expansion of FDA oversight over laboratory developed tests (LDTs).
Companion diagnostics are increasingly integral to the approval of some new pharmaceuticals, illustrating which individuals are most likely to benefit from the drug. With the approval of CDx-assisted therapies, new high-growth markets are opened for lab tests and IVD products.
Companion diagnostics (CDx) include in vivo or medical imaging procedures and in vitro diagnostic (IVD) lab tests used to determine the efficacy of a particular therapy, most commonly pharmaceutical. Genome research in recent decades has illuminated and detailed the role genetics play in drug metabolism and disease etiology. Drugs can now be paired with IVD and medical imaging tests for prescription decisions and therapeutic monitoring. In vitro companion diagnostics are largely molecular assays, though additional formats include immunohistochemistry (IHC) and immunoassays, and are offered as test kits, analyte specific reagents, and laboratory developed tests (LDTs) or a lab testing service.
The majority of companion diagnostics are pharmacodiagnostic lab tests used to assess an individual’s response to drug therapy. Pharmacodiagnostics represents a major front in a healthcare system-wide push towards personalized medicine. Pharmacodiagnostic tests can be used to determine patient response to clopidogrel anticoagulant drugs, appropriate drug dosage, and the prescription of oncology drugs based on genetic markers.
Stay abreast of fast-paced and promising companion diagnostics markets with MarketResearch.com’s collection of market research studies. We offer a wide selection of studies treating companion diagnostic regulation, regional and disease-specific market development, product and test pipelines, and companion diagnostic product market tracking.
Companion Diagnostics Industry Research & Market Reports
-
Companion Diagnostics Market - A Global and Regional Analysis: Focus on Application, End User, Technology, and Region - Analysis and Forecast, 2023-2033
... at $3,762.0 million in 2023 and is expected to reach $12,498.7 million by 2033, growing at a CAGR of 12.76% between 2023 and 2033. The growth of the companion diagnostics market is driven by the ... Read More
-
2024 Global: Companion Diagnostics Market - Innovative Markets Forecast (2030) report
... 2019 through 2030. Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2019 to 2030 using regression ... Read More
-
FISH Probe Market Size, Trends, Analysis, and Outlook By Technology (Q FISH, FLOW FISH, Others), By Type (DNA, RNA), By Application (Cancer research, Genetic diseases, Others), By End-User (Research, Clinical, Companion diagnostics), by Region, Country, Segment, and Companies, 2024-2030
... Segment, and Companies, 2024-2030 The global FISH Probe market size is poised to register 8.28% growth (CAGR) from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes ... Read More
-
Cancer Diagnostic Devices Market Size, Trends, Analysis, and Outlook By Product (Molecular Diagnostics, Companion Diagnostics), By Diagnostic (Diagnostic Imaging Tests, Biopsy and Cytology Tests, Tumor Biomarkers, Others), by Region, Country, Segment, and Companies, 2024-2030
... global Cancer Diagnostic Devices market size is poised to register 9.79% growth (CAGR) from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Cancer Diagnostic ... Read More
-
Clinical Oncology Next Generation Sequencing Market Size, Trends, Analysis, and Outlook By Technology (Whole Genome Sequencing, Whole Exome Sequencing, Targeted Sequencing & Resequencing Centrifuges), By Workflow (NGS Pre-Sequencing, NGS Sequencing, NGS Data Analysis), By Application (Screening, Companion Diagnostics, Others), By End-User (Hospitals, Clinics, Laboratories), by Region, Country, Segment, and Companies, 2024-2030
... (Screening, Companion Diagnostics, Others), By End-User (Hospitals, Clinics, Laboratories), by Region, Country, Segment, and Companies, 2024-2030 The global Clinical Oncology Next Generation Sequencing market size is poised to register 15.5% growth from 2024 to 2030, ... Read More
-
Next Generation Cancer Diagnostics Market Size, Trends, Analysis, and Outlook By Technology (Next-generation Sequencing, qPCR & Multiplexing, Lab-on- a- chip (LOAC) & Reverse Transcriptase-PCR (RT-PCR), Protein Microarrays, DNA Microarrays), By Application (Biomarker Development, CTC Analysis, Proteomic Analysis, Epigenetic Analysis, Genetic Analysis), By Cancer Type (Lung Cancer, Breast Cancer, Colorectal Cancer, Cervical Cancer, Others), By Function, Therapeutic Monitoring, Companion Diagnostics, Prognostics, Cancer Screening, Risk Analysis), by Region, Country, Segment, and Companies, 2024-2030
... Proteomic Analysis, Epigenetic Analysis, Genetic Analysis), By Cancer Type (Lung Cancer, Breast Cancer, Colorectal Cancer, Cervical Cancer, Others), By Function, Therapeutic Monitoring, Companion Diagnostics, Prognostics, Cancer Screening, Risk Analysis), by Region, Country, Segment, and Companies, ... Read More
-
The 2025-2030 World Outlook for Companion Diagnostics
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2025-2030 World Outlook for Oncology Companion Diagnostics
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2025-2030 World Outlook for Tissue Diagnostic Devices
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2025-2030 World Outlook for Companion Animal Diagnostics
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2025-2030 World Outlook for Companion Diagnostics Assay Kits and Reagents
... given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative ... Read More
-
Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Growth (Status and Outlook) 2024-2030
... was valued at US$ 9383.3 million in 2023. With growing demand in downstream market, the Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) is forecast to a readjusted size of US$ 25340 million by 2030 ... Read More
-
Europe Companion Diagnostics - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2021 - 2029
... USD 2.01 billion by 2029, growing at a CAGR of 9.23% during the forecast period (2024-2029). The COVID-19 pandemic initially had a substantial impact on the companion diagnostics market. The usage of companion diagnostic products ... Read More
-
North America Radiopharmaceutical Theranostics Market Forecast to 2028 - Regional Analysis - by Product Type [Alpha Emitters, Beta Emitters, and Positron Emission Tomography (PET) Tracers], Radioisotope [Technetium-99, Gallium-68, Iodine-131, Iodine-123, Fluorine-18 (18F), Yttrium 90 (Y-90), Lutetium (Lu) 177, Copper (Cu) 67, Copper (Cu) 64, and Others], Source (Nuclear Reactors and Cyclotrons), Application [Targeted Therapeutic (Rx) and Companion Diagnostic (CDx)], Indication (Oncology, Cardiology, Neurology, and Others), and End User (Hospitals, Diagnostic Imaging Centers, Academic and Research Institutes, and Others)
... Lutetium (Lu) 177, Copper (Cu) 67, Copper (Cu) 64, and Others], Source (Nuclear Reactors and Cyclotrons), Application [Targeted Therapeutic (Rx) and Companion Diagnostic (CDx)], Indication (Oncology, Cardiology, Neurology, and Others), and End User (Hospitals, Diagnostic ... Read More
-
In Vitro Diagnostics Business Outlook, 2024
... Diagnostics Business Outlook is a bimonthly publication with six issues annually. In Vitro Diagnostics Business Outlook offers information and data that you cannot get anywhere else, including: Market data and forecasts (growth rates, market size, ... Read More
-
Companion Diagnostics (CDx) Market Report 2024-2034
... underlying dynamics better. It will be useful for companies that want to expand into different industries or their existing operations in a new region. Technological Improvements in the CDx Market The market for CDx is ... Read More
-
The World Market for Veterinary Diagnostics, 7th Edition
... on swift, reliable, and accurate methods, facilitating informed diagnoses. Despite various challenges, the veterinary diagnostics market has shown consistent growth and is forecasted to continue on this trajectory. This sector presents a rapidly expanding market ... Read More
-
Companion Diagnostics Market by Technology (Immunohistochemistry, In Situ Hybridization, Next-Generation Sequencing), Indication (Breast Cancer, Colorectal Cancer, Leukemia), End-User - Global Forecast 2024-2030
... and expected to reach USD 2.92 billion in 2024, at a CAGR 11.55% to reach USD 5.63 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Companion Diagnostics Market. ... Read More
-
Precision Medicine Market by Technology (Big Data Analytics, Bioinformatics, Companion Diagnostics), Application (CNS, Immunology, Oncology), End-User, Deployment - Global Forecast 2024-2030
... expected to reach USD 75.70 billion in 2024, at a CAGR 11.22% to reach USD 143.43 billion by 2030. Global Precision Medicine Market Precision medicine refers to the strategy of tailoring disease prevention and treatment ... Read More
-
Global Companion Diagnostics Market Research Report 2024(Status and Outlook)
... exhibiting a CAGR of 13.20% during the forecast period. This report provides a deep insight into the global Companion Diagnostics market covering all its essential aspects. This ranges from a macro overview of the market ... Read More
-
Global Pharmacogenomics Technology and Theranostics and Companion Diagnostics (CDx) Market Research Report 2024(Status and Outlook)
... in 2023 and is projected to reach USD 9612.04 million by 2029, exhibiting a CAGR of 14.70% during the forecast period. This report provides a deep insight into the global Pharmacogenomics Technology and Theranostics and ... Read More
-
Global Companion Diagnostics for Oncology Market Research Report 2024(Status and Outlook)
... information about the effective use of a corresponding therapeutic product by analyzing the genetic material. With the rise in cancer prevalence, coupled with increasing strategic initiatives, there has been a huge demand for companion diagnostics ... Read More
-
Companion Diagnostics Market, By Technology Type (Real Time-Polymerase Chain Reactions (PCR), Gene Sequencing, Fluorescence in situ Hybridization, and Others) By Application (Oncology, Cardiovascular Diseases, Infectious Diseases, Neurological Diseases and Others), By End User (Hospitals, Research Laboratories, Biopharmaceutical companies, and Others), By Region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa)
... Laboratories, Biopharmaceutical companies, and Others), By Region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa) Companion diagnostics are medical devices that are used to detect specific biomarkers or genes in patients that ... Read More
-
Genomic Cancer Testing Market, By Test Type (Genomic Profiling Tests, Liquid Biopsy Tests, Companion Diagnostic Tests, Pharmacogenomic Tests, Hereditary Cancer Tests, Other specialized genomic tests), By Cancer Type (Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Ovarian Cancer, Melanoma, Leukemia, Lymphoma, Other specific cancer types), By Technology (Next-Generation Sequencing, Polymerase Chain Reaction, Fluorescence In Situ Hybridization, Microarray, Immunohistochemistry, Other genomic testing technologies), By End-User (Hospitals, Diagnostic Laboratories, Academic and Research Institutions, Cancer Centers, Other healthcare providers), By Biomarker Type (Genetic Biomarkers, Protein Biomarkers, Molecular Biomarkers, Epigenetic Biomarkers), By Service Provider (Diagnostic Laboratories, Biotechnology Companies, Pharmaceutical Companies, Contract Research Organizations), By Application (Targeted Therapy Selection, Disease Monitoring, Prognostic Testing, Companion Diagno
... Cancer, Ovarian Cancer, Melanoma, Leukemia, Lymphoma, Other specific cancer types), By Technology (Next-Generation Sequencing, Polymerase Chain Reaction, Fluorescence In Situ Hybridization, Microarray, Immunohistochemistry, Other genomic testing technologies), By End-User (Hospitals, Diagnostic Laboratories, Academic and Research ... Read More
-
Companion Diagnostics Global Market Report 2024
... Cancer; Colorectal Cancer; Leukemia; Melanoma4) By End-User: Pharmaceutical And Biopharmaceutical Companies; Reference Laboratories; Contract Research OrganizationsCovering: F Hoffmann-La Roche Ltd.; Agilent Technologies Inc.; Qiagen NV; Thermo Fisher Scientific Inc.; Abbott Laboratories Inc. Companion Diagnostics Global ... Read More
Research Assistance
